Status:
COMPLETED
Clinical Trials in Organ Transplantation Extension Study
Lead Sponsor:
Duke University
Collaborating Sponsors:
Cystic Fibrosis Foundation
Conditions:
Lung Transplant Failure and Rejection
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to continue to follow subjects who were enrolled in the CTOT-20 CLAD Phenotypes study. Subjects will provide clinical data and complete quality of life questionnaires that ...
Detailed Description
There are no mandated study visits, rather the study will be conducted using real world data collected as part of usual clinical care according to the standard of care transplant protocols at each sit...
Eligibility Criteria
Inclusion
- Current CTOT-20 participants
Exclusion
- Non-CTOT-20 participants
- Withdrawn CTOT-20 participants
Key Trial Info
Start Date :
December 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 26 2024
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT04126746
Start Date
December 17 2019
End Date
August 26 2024
Last Update
March 21 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles Medical Center
Los Angeles, California, United States, 90024
2
Johns Hopkins University
Baltimore, Maryland, United States, 21224
3
Duke University Medical Center
Durham, North Carolina, United States, 27710
4
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195